Xiao-Nong Zhou Selected Research

Xiao-Nong Zhou Research Topics

Disease

35	Infections 01/2024 - 10/2007
21	Schistosomiasis (Bilharziasis) 07/2023 - 02/2005
19	Malaria 12/2023 - 12/2013
5	Reinfection 12/2022 - 01/2012
5	Parasitic Diseases (Parasitic Disease) 10/2022 - 03/2013
5	Clonorchiasis 01/2022 - 04/2013
4	COVID-19 04/2023 - 10/2020
4	Echinococcosis (Hydatid Cysts) 04/2021 - 09/2017
3	Helminthiasis (Helminthiases) 01/2022 - 01/2012
3	Babesiosis (Piroplasmosis) 07/2018 - 11/2014
3	Communicable Diseases (Infectious Diseases) 05/2017 - 10/2012
3	Hookworm Infections (Hookworm Infection) 01/2015 - 01/2011
3	Coinfection 08/2014 - 02/2012
3	Schistosomiasis japonica 08/2011 - 06/2007
2	Dengue (Dengue Fever) 08/2022 - 11/2018
2	Disease Progression 03/2020 - 07/2018
2	Cysticercosis 01/2020 - 11/2018
2	Neglected Diseases 03/2017 - 12/2016
2	Filarial Elephantiasis (Lymphatic Filariasis) 12/2015 - 01/2014
1	Zoonoses 04/2024
1	Post-Acute COVID-19 Syndrome 04/2023
1	Opisthorchiasis 01/2022
1	Schistosomiasis mansoni 11/2021
1	Trematode Infections (Fasciolopsiasis) 01/2021
1	Mosquito-Borne Diseases 01/2021
1	Cysts 03/2020
1	Taeniasis 01/2020
1	Schistosomiasis haematobia (Schistosomiasis haematobium) 09/2019
1	Diarrhea 05/2018
1	Cestode Infections (Tapeworm Infection) 09/2017

Drug/Important Bio-Agent (IBA)

14	Praziquantel (Biltricide)FDA Link 07/2023 - 02/2005
11	AntigensIBA 01/2020 - 12/2007
6	tribendimidineIBA 01/2024 - 01/2008
6	Biomarkers (Surrogate Marker)IBA 09/2023 - 02/2014
6	VaccinesIBA 10/2020 - 02/2014
5	Albendazole (Albenza)FDA Link 01/2022 - 01/2011
5	Indicators and Reagents (Reagents)IBA 05/2021 - 12/2013
3	InsecticidesIBA 01/2021 - 01/2020
3	artemisinin (artemisinine)IBA 09/2020 - 12/2015
3	Complement System Proteins (Complement)IBA 05/2020 - 01/2015
3	Immunoglobulin G (IgG)IBA 03/2020 - 04/2013
3	CytokinesIBA 03/2020 - 02/2012
3	Proteins (Proteins, Gene)FDA Link 07/2018 - 01/2012
2	hydroxide ionIBA 04/2024 - 10/2008
2	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 01/2012
2	SolutionsIBA 11/2023 - 12/2016
2	FMRFamideIBA 01/2023 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2023 - 05/2015
2	Antimalarials (Antimalarial Agents)IBA 02/2021 - 01/2014
2	AntibodiesIBA 03/2020 - 01/2015
2	Interleukin-2 (IL2)IBA 03/2020 - 02/2012
2	Ivermectin (Mectizan)FDA Link 11/2018 - 12/2015
2	Inosine Diphosphate (IDP)IBA 05/2017 - 10/2012
2	Mebendazole (Anti-Worm)FDA Link 08/2014 - 01/2011
2	ImmunosorbentsIBA 01/2012 - 06/2007
2	EnzymesIBA 01/2012 - 06/2007
1	A 17 (A-17)IBA 12/2023
1	Recombinases (Recombinase)IBA 11/2023
1	Antiviral Agents (Antivirals)IBA 09/2023
1	Interleukin-6 (Interleukin 6)IBA 04/2023
1	Sodium Channels (Sodium Channel)IBA 01/2023
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 11/2022
1	SilverIBA 10/2022
1	AntioxidantsIBA 10/2022
1	Moclobemide (Arima)IBA 08/2022
1	mahuang-tangIBA 01/2022
1	ethyl acetateIBA 01/2022
1	AnthelminticsIBA 01/2022
1	Formaldehyde (Formol)FDA Link 01/2022
1	Nucleic AcidsIBA 11/2021
1	Peptides (Polypeptides)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	NeuropeptidesIBA 01/2021
1	plasmepsin IIIBA 09/2020
1	ArtesunateIBA 07/2020
1	Genetic Markers (Genetic Marker)IBA 03/2020
1	ChemokinesIBA 03/2020
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 03/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2020
1	Interleukin-17 (Interleukin 17)IBA 03/2020
1	Interleukin-8 (Interleukin 8)IBA 03/2020
1	Guanosine Diphosphate (GDP)IBA 03/2020
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 11/2018
1	Recombinant ProteinsIBA 07/2018
1	Gentamicins (Gentamicin)FDA LinkGeneric 05/2018
1	Amoxicillin (Wymox)FDA LinkGeneric 05/2018
1	Ciprofloxacin (Cipro)FDA LinkGeneric 05/2018
1	Cephalothin (Cefalotin)FDA Link 05/2018
1	Sulfamethoxazole FDA LinkGeneric 05/2018
1	Trimethoprim (Proloprim)FDA LinkGeneric 05/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2018
1	Immunoglobulin M (IgM)IBA 01/2018

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 12/2022 - 02/2014
5	Therapeutics 09/2023 - 03/2013
3	Mass Drug Administration 01/2022 - 01/2015
2	Transcutaneous Electric Nerve Stimulation (TENS) 02/2022 - 12/2013
2	Aftercare (After-Treatment) 10/2013 - 01/2012
1	Highly Active Antiretroviral Therapy (HAART) 09/2023
1	Chemoprevention 07/2020